Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer.
Authors: Wang, Wenjing1,2 (AUTHOR), Zhao, Mengyue1,2 (AUTHOR), Cui, Lijuan1,2 (AUTHOR), Ren, Yong3 (AUTHOR), Zhang, Jingyuan1,2 (AUTHOR), Chen, Junli1,2 (AUTHOR), Jia, Lina1,2 (AUTHOR), Zhang, Jiayu1,2 (AUTHOR), Yang, Jingyu1,2 (AUTHOR), Chen, Guoliang4 (AUTHOR), Ashby, Charles R.5 (AUTHOR), Wu, Chunfu1,2 (AUTHOR) wucf@syphu.edu.cn, Chen, Zhe-Sheng5 (AUTHOR) chenz@stjohns.edu, Wang, Lihui1,2 (AUTHOR) lhwang@syphu.edu.cn
Source: Molecular Cancer. 9/2/2020, Vol. 19 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14764598
DOI:10.1186/s12943-020-01256-9